 | • レポートコード：D005-00782 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、変形性関節症疼痛ソリューション の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性関節症疼痛ソリューション の種類別市場規模（経口、注射、外用）、用途別市場規模（医療、パーソナルケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Horizon Pharma、Bayer、Johnson and Johnson、Sanofi、GlaxoSmithKline、Mylan、Novartis、Eli Lilly、Abbott、Tide Pharmaceutical、Abiogen Pharma、Daiichi Sankyo、Iroko Pharmaceuticals、Astellas Pharma、TEVA、Hengrui Pharmaceutical、Almatica Pharma ・地域別グローバル市場分析 2015年-2020年 ・変形性関節症疼痛ソリューション の北米市場（アメリカ、カナダ、メキシコ） ・変形性関節症疼痛ソリューション のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・変形性関節症疼痛ソリューション のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・変形性関節症疼痛ソリューション の南米市場（ブラジル、アルゼンチン） ・変形性関節症疼痛ソリューション の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射、外用 ・用途別分析：医療、パーソナルケア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Osteoarthritis Pain Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Osteoarthritis Pain Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Osteoarthritis Pain Solution market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Osteoarthritis Pain Solution market has been segmented into:
Oral
Injection
External
By Application, Osteoarthritis Pain Solution has been segmented into:
Medical Care
Personal Care
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Osteoarthritis Pain Solution market presented in the report. This section sheds light on the sales growth of different regional and country-level Osteoarthritis Pain Solution markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Osteoarthritis Pain Solution market.
The report offers in-depth assessment of the growth and other aspects of the Osteoarthritis Pain Solution market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Osteoarthritis Pain Solution Market Share Analysis
Osteoarthritis Pain Solution competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Osteoarthritis Pain Solution sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Osteoarthritis Pain Solution sales, revenue and market share for each player covered in this report.
The major players covered in Osteoarthritis Pain Solution are:
Pfizer
Horizon Pharma
Bayer
Johnson and Johnson
Sanofi
GlaxoSmithKline
Mylan
Novartis
Eli Lilly
Abbott
Tide Pharmaceutical
Abiogen Pharma
Daiichi Sankyo
Iroko Pharmaceuticals
Astellas Pharma
TEVA
Hengrui Pharmaceutical
Almatica Pharma
Table of Contents
1 Osteoarthritis Pain Solution Market Overview
1.1 Product Overview and Scope of Osteoarthritis Pain Solution
1.2 Classification of Osteoarthritis Pain Solution by Type
1.2.1 Global Osteoarthritis Pain Solution Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Osteoarthritis Pain Solution Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injection
1.2.5 External
1.3 Global Osteoarthritis Pain Solution Market by Application
1.3.1 Overview: Global Osteoarthritis Pain Solution Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Osteoarthritis Pain Solution Market by Regions
1.4.1 Global Osteoarthritis Pain Solution Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Osteoarthritis Pain Solution (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Osteoarthritis Pain Solution Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Osteoarthritis Pain Solution Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Osteoarthritis Pain Solution Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Osteoarthritis Pain Solution Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Osteoarthritis Pain Solution Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson and Johnson
2.4.1 Johnson and Johnson Details
2.4.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson and Johnson SWOT Analysis
2.4.4 Johnson and Johnson Product and Services
2.4.5 Johnson and Johnson Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly SWOT Analysis
2.9.4 Eli Lilly Product and Services
2.9.5 Eli Lilly Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.11 Tide Pharmaceutical
2.11.1 Tide Pharmaceutical Details
2.11.2 Tide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Tide Pharmaceutical SWOT Analysis
2.11.4 Tide Pharmaceutical Product and Services
2.11.5 Tide Pharmaceutical Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.12 Abiogen Pharma
2.12.1 Abiogen Pharma Details
2.12.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Abiogen Pharma SWOT Analysis
2.12.4 Abiogen Pharma Product and Services
2.12.5 Abiogen Pharma Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Daiichi Sankyo SWOT Analysis
2.13.4 Daiichi Sankyo Product and Services
2.13.5 Daiichi Sankyo Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.14 Iroko Pharmaceuticals
2.14.1 Iroko Pharmaceuticals Details
2.14.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Iroko Pharmaceuticals SWOT Analysis
2.14.4 Iroko Pharmaceuticals Product and Services
2.14.5 Iroko Pharmaceuticals Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.15 Astellas Pharma
2.15.1 Astellas Pharma Details
2.15.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Astellas Pharma SWOT Analysis
2.15.4 Astellas Pharma Product and Services
2.15.5 Astellas Pharma Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.16 TEVA
2.16.1 TEVA Details
2.16.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 TEVA SWOT Analysis
2.16.4 TEVA Product and Services
2.16.5 TEVA Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hengrui Pharmaceutical SWOT Analysis
2.17.4 Hengrui Pharmaceutical Product and Services
2.17.5 Hengrui Pharmaceutical Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
2.18 Almatica Pharma
2.18.1 Almatica Pharma Details
2.18.2 Almatica Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Almatica Pharma SWOT Analysis
2.18.4 Almatica Pharma Product and Services
2.18.3 Almatica Pharma Osteoarthritis Pain Solution Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Osteoarthritis Pain Solution Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Osteoarthritis Pain Solution Players Market Share
3.2.2 Top 10 Osteoarthritis Pain Solution Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Osteoarthritis Pain Solution Revenue and Market Share by Regions
4.2 North America Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
4.3 Europe Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
4.5 South America Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
5 North America Osteoarthritis Pain Solution Revenue by Countries
5.1 North America Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
5.2 USA Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
5.3 Canada Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
5.4 Mexico Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
6 Europe Osteoarthritis Pain Solution Revenue by Countries
6.1 Europe Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
6.2 Germany Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
6.3 UK Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
6.4 France Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
6.5 Russia Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
6.6 Italy Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Osteoarthritis Pain Solution Revenue by Countries
7.1 Asia-Pacific Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
7.2 China Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
7.3 Japan Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
7.4 Korea Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
7.5 India Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
8 South America Osteoarthritis Pain Solution Revenue by Countries
8.1 South America Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
8.2 Brazil Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
8.3 Argentina Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Osteoarthritis Pain Solution by Countries
9.1 Middle East & Africa Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
9.2 Saudi Arabia Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
9.3 UAE Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
9.4 Egypt Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
9.5 South Africa Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Osteoarthritis Pain Solution Revenue and Market Share by Type (2015-2020)
10.2 Global Osteoarthritis Pain Solution Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
10.5 External Revenue Growth Rate (2015-2025)
11 Global Osteoarthritis Pain Solution Market Segment by Application
11.1 Global Osteoarthritis Pain Solution Revenue Market Share by Application (2015-2020)
11.2 Osteoarthritis Pain Solution Market Forecast by Application (2019-2024)
11.3 Medical Care Revenue Growth (2015-2020)
11.4 Personal Care Revenue Growth (2015-2020)
12 Global Osteoarthritis Pain Solution Market Size Forecast (2021-2025)
12.1 Global Osteoarthritis Pain Solution Market Size Forecast (2021-2025)
12.2 Global Osteoarthritis Pain Solution Market Forecast by Regions (2021-2025)
12.3 North America Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
12.4 Europe Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
12.6 South America Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Osteoarthritis Pain Solution Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Osteoarthritis Pain Solution by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Osteoarthritis Pain Solution Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Osteoarthritis Pain Solution Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Osteoarthritis Pain Solution Major Business
Table 7. Pfizer Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Osteoarthritis Pain Solution Product and Solutions
Table 10. Pfizer Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Horizon Pharma Corporate Information, Location and Competitors
Table 12. Horizon Pharma Osteoarthritis Pain Solution Major Business
Table 13. Horizon Pharma Osteoarthritis Pain Solution Total Revenue (USD Million) (2018-2019)
Table 14. Horizon Pharma SWOT Analysis
Table 15. Horizon Pharma Osteoarthritis Pain Solution Product and Solutions
Table 16. Horizon Pharma Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bayer Corporate Information, Location and Competitors
Table 18. Bayer Osteoarthritis Pain Solution Major Business
Table 19. Bayer Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 20. Bayer SWOT Analysis
Table 21. Bayer Osteoarthritis Pain Solution Product and Solutions
Table 22. Bayer Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson and Johnson Corporate Information, Location and Competitors
Table 24. Johnson and Johnson Osteoarthritis Pain Solution Major Business
Table 25. Johnson and Johnson Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 26. Johnson and Johnson SWOT Analysis
Table 27. Johnson and Johnson Osteoarthritis Pain Solution Product and Solutions
Table 28. Johnson and Johnson Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Osteoarthritis Pain Solution Major Business
Table 31. Sanofi Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Osteoarthritis Pain Solution Product and Solutions
Table 34. Sanofi Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GlaxoSmithKline Corporate Information, Location and Competitors
Table 36. GlaxoSmithKline Osteoarthritis Pain Solution Major Business
Table 37. GlaxoSmithKline Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Osteoarthritis Pain Solution Product and Solutions
Table 40. GlaxoSmithKline Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Mylan Corporate Information, Location and Competitors
Table 42. Mylan Osteoarthritis Pain Solution Major Business
Table 43. Mylan Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 44. Mylan SWOT Analysis
Table 45. Mylan Osteoarthritis Pain Solution Product and Solutions
Table 46. Mylan Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Corporate Information, Location and Competitors
Table 48. Novartis Osteoarthritis Pain Solution Major Business
Table 49. Novartis Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 50. Novartis SWOT Analysis
Table 51. Novartis Osteoarthritis Pain Solution Product and Solutions
Table 52. Novartis Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Eli Lilly Corporate Information, Location and Competitors
Table 54. Eli Lilly Osteoarthritis Pain Solution Major Business
Table 55. Eli Lilly Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 56. Eli Lilly SWOT Analysis
Table 57. Eli Lilly Osteoarthritis Pain Solution Product and Solutions
Table 58. Eli Lilly Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Abbott Corporate Information, Location and Competitors
Table 60. Abbott Osteoarthritis Pain Solution Major Business
Table 61. Abbott Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 62. Abbott SWOT Analysis
Table 63. Abbott Osteoarthritis Pain Solution Product and Solutions
Table 64. Abbott Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Tide Pharmaceutical Corporate Information, Location and Competitors
Table 66. Tide Pharmaceutical Osteoarthritis Pain Solution Major Business
Table 67. Tide Pharmaceutical Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 68. Tide Pharmaceutical SWOT Analysis
Table 69. Tide Pharmaceutical Osteoarthritis Pain Solution Product and Solutions
Table 70. Tide Pharmaceutical Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Abiogen Pharma Corporate Information, Location and Competitors
Table 72. Abiogen Pharma Osteoarthritis Pain Solution Major Business
Table 73. Abiogen Pharma Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 74. Abiogen Pharma SWOT Analysis
Table 75. Abiogen Pharma Osteoarthritis Pain Solution Product and Solutions
Table 76. Abiogen Pharma Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Daiichi Sankyo Corporate Information, Location and Competitors
Table 78. Daiichi Sankyo Osteoarthritis Pain Solution Major Business
Table 79. Daiichi Sankyo Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 80. Daiichi Sankyo SWOT Analysis
Table 81. Daiichi Sankyo Osteoarthritis Pain Solution Product and Solutions
Table 82. Daiichi Sankyo Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Iroko Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Iroko Pharmaceuticals Osteoarthritis Pain Solution Major Business
Table 85. Iroko Pharmaceuticals Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 86. Iroko Pharmaceuticals SWOT Analysis
Table 87. Iroko Pharmaceuticals Osteoarthritis Pain Solution Product and Solutions
Table 88. Iroko Pharmaceuticals Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Astellas Pharma Corporate Information, Location and Competitors
Table 90. Astellas Pharma Osteoarthritis Pain Solution Major Business
Table 91. Astellas Pharma Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 92. Astellas Pharma SWOT Analysis
Table 93. Astellas Pharma Osteoarthritis Pain Solution Product and Solutions
Table 94. Astellas Pharma Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. TEVA Corporate Information, Location and Competitors
Table 96. TEVA Osteoarthritis Pain Solution Major Business
Table 97. TEVA Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 98. TEVA SWOT Analysis
Table 99. TEVA Osteoarthritis Pain Solution Product and Solutions
Table 100. TEVA Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Hengrui Pharmaceutical Corporate Information, Location and Competitors
Table 102. Hengrui Pharmaceutical Osteoarthritis Pain Solution Major Business
Table 103. Hengrui Pharmaceutical Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 104. Hengrui Pharmaceutical SWOT Analysis
Table 105. Hengrui Pharmaceutical Osteoarthritis Pain Solution Product and Solutions
Table 106. Hengrui Pharmaceutical Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Almatica Pharma Osteoarthritis Pain Solution Type and Application
Table 108. Almatica Pharma Osteoarthritis Pain Solution Major Business
Table 109. Almatica Pharma Osteoarthritis Pain Solution Total Revenue (USD Million) (2017-2018)
Table 110. Almatica Pharma SWOT Analysis
Table 111. Almatica Pharma Osteoarthritis Pain Solution Product and Solutions
Table 112. Almatica Pharma Osteoarthritis Pain Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Global Osteoarthritis Pain Solution Revenue (Million USD) by Players (2015-2020)
Table 114. Global Osteoarthritis Pain Solution Revenue Share by Players (2015-2020)
Table 115. Global Osteoarthritis Pain Solution Revenue (Million USD) by Regions (2015-2020)
Table 116. Global Osteoarthritis Pain Solution Revenue Market Share by Regions (2015-2020)
Table 117. North America Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
Table 118. North America Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Table 119. Europe Osteoarthritis Pain Solution Revenue (Million USD) by Countries (2015-2020)
Table 120. Asia-Pacific Osteoarthritis Pain Solution Revenue (Million USD) by Countries (2015-2020)
Table 121. South America Osteoarthritis Pain Solution Revenue by Countries (2015-2020)
Table 122. South America Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Table 123. Middle East and Africa Osteoarthritis Pain Solution Revenue (Million USD) by Countries (2015-2020)
Table 124. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Table 125. Global Osteoarthritis Pain Solution Revenue (Million USD) by Type (2015-2020)
Table 126. Global Osteoarthritis Pain Solution Revenue Share by Type (2015-2020)
Table 127. Global Osteoarthritis Pain Solution Revenue Forecast by Type (2021-2025)
Table 128. Global Osteoarthritis Pain Solution Revenue by Application (2015-2020)
Table 129. Global Osteoarthritis Pain Solution Revenue Share by Application (2015-2020)
Table 130. Global Osteoarthritis Pain Solution Revenue Forecast by Application (2021-2025)
Table 131. Global Osteoarthritis Pain Solution Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Osteoarthritis Pain Solution Picture
Figure 2. Global Osteoarthritis Pain Solution Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. External Picture
Figure 6. Osteoarthritis Pain Solution Revenue Market Share by Application in 2019
Figure 7. Medical Care Picture
Figure 8. Personal Care Picture
Figure 9. Global Osteoarthritis Pain Solution Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Osteoarthritis Pain Solution Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Osteoarthritis Pain Solution Revenue Market Share in 2019
Figure 18. Global Top 10 Players Osteoarthritis Pain Solution Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Osteoarthritis Pain Solution Revenue Market Share by Regions (2015-2020)
Figure 22. Global Osteoarthritis Pain Solution Revenue Market Share by Regions in 2018
Figure 23. North America Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 24. Europe Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 26. South America Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 28. North America Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Figure 29. North America Osteoarthritis Pain Solution Revenue Market Share by Countries in 2019
Figure 30. USA Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 31. Canada Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 33. Europe Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Osteoarthritis Pain Solution Revenue Market Share by Countries in 2019
Figure 35. Germany Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 36. UK Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 37. France Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 38. Russia Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 39. Italy Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Osteoarthritis Pain Solution Revenue Market Share by Countries in 2019
Figure 42. China Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 43. Japan Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 44. Korea Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 45. India Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 47. South America Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Figure 48. South America Osteoarthritis Pain Solution Revenue Market Share by Countries in 2019
Figure 49. Brazil Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 54. UAE Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Osteoarthritis Pain Solution Revenue and Growth Rate (2015-2020)
Figure 57. Global Osteoarthritis Pain Solution Revenue Share by Type (2015-2020)
Figure 58. Global Osteoarthritis Pain Solution Revenue Share by Type in 2019
Figure 59. Global Osteoarthritis Pain Solution Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral Revenue Growth Rate (2015-2020)
Figure 61. Global Injection Revenue Growth Rate (2015-2020)
Figure 62. Global External Revenue Growth Rate (2015-2020)
Figure 63. Global Osteoarthritis Pain Solution Revenue Share by Application (2015-2020)
Figure 64. Global Osteoarthritis Pain Solution Revenue Share by Application in 2019
Figure 65. Global Osteoarthritis Pain Solution Market Share Forecast by Application (2021-2025)
Figure 66. Global Medical Care Revenue Growth Rate (2015-2020)
Figure 67. Global Personal Care Revenue Growth Rate (2015-2020)
Figure 68. Global Osteoarthritis Pain Solution Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Osteoarthritis Pain Solution Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Osteoarthritis Pain Solution Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
Figure 72. Europe Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
Figure 74. South America Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
変形性関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medicine for Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medicine fo…- 変形性股関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hip Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hip Osteoarthri…
- 変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis …
- 脊椎変形性関節症用鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Spine Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Spine Osteoar…
- 脊椎変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Spine Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Spine Ost…